Trial NCT04492254

View at ClinicalTrials.gov 
Org. Study IDs: TRI-08892
Secondary IDs: 2020-003125-39

Last trial update was posted on 2022-05-02

MeSH Interventions

Enoxaparin

MeSH Conditions

COVID-19

Other Conditions


Stopping Reasons

Average event rate (end point) was much lower than expected. A larger sample size would have been required to maintain same statistical power, which was not achievable in a feasible time scale. No safety concerns were identified with bleeding.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID